Twinbeech Capital LP United Therapeutics Corp Transaction History

Twinbeech Capital LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $14.5 Million - $17.3 Million	67,518 Added 2456.09%	70,267 $15.5 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $582,293 - $682,411	2,749 New	2,749 $620,000
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $3.96 Million - $4.64 Million	-21,466 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $3.86 Million - $4.61 Million	21,466 New	21,466 $3.96 Million
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $333,041 - $483,893	-4,195 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $328,510 - $399,951	4,195 New	4,195 $369,000

679

42.1M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.